What GLP-1 medications cost in 2026: Brand, compounded, and lower-dose options

GLP-1 prices vary more than almost any other drug category, and the range is wide enough to be genuinely confusing. This article breaks down what brand-name, compounded, and lower-dose GLP-1 options actually cost, what insurance does and does not typically cover, and where microdosing fits into the cost picture. It is educational content, not medical advice, and none of the figures below are Luvo's own pricing, which is listed separately on the Pricing page.

Why GLP-1 prices are so spread out

A single GLP-1 medication can show up at wildly different price points depending on the path you take to get it: full list price through a standard pharmacy, a manufacturer's direct-to-consumer discount program, an insurance copay, or a compounded formulation through a telehealth provider. Before recent manufacturer discount programs, Wegovy's list price ran around $1,349 per month without insurance or a savings program [1]. That gap between list price and what people actually pay is the main reason "how much does a GLP-1 cost" does not have one answer, and it is also why marketplace listings and sponsored content advertising a single "cheapest GLP-1" number are usually describing one specific path, not the market as a whole.

Brand-name medications: Ozempic, Wegovy, Zepbound

Ozempic (semaglutide) and Wegovy (semaglutide) are made by Novo Nordisk; Zepbound (tirzepatide) is made by Eli Lilly. All three are prescription-only and FDA-approved for their labeled indications. Ozempic, Wegovy, and Zepbound are trademarks of their respective manufacturers. Luvo Health is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.

As of late 2025, Novo Nordisk's direct-to-consumer cash price for most doses of Wegovy and Ozempic is $349 per month, with the highest Ozempic dose (2 mg) remaining at $499 per month; a temporary introductory offer has also made the two lowest doses available at $199 per month for a new cash-paying patient's first two months [2]. Eli Lilly's self-pay pricing for Zepbound vials, through its LillyDirect Self Pay Journey Program, runs $299 per month for the starter 2.5 mg dose, $399 per month for the 5 mg dose, and $449 per month for higher doses [3]. Wegovy's oral pill formulation has also become available at a cash price as low as $149 per month through certain pharmacy partners [4]. These figures are current as of the sources cited and change frequently as manufacturers adjust their programs, so treat them as a snapshot rather than a fixed number.

With insurance

Whether insurance covers a GLP-1, and at what cost to you, depends heavily on the reason it is prescribed and the specific plan. Coverage for GLP-1s prescribed for type 2 diabetes is common. Coverage specifically for weight loss is much less consistent: a 2025 employer survey found that only 19% of employers cover GLP-1 medications for weight loss overall, though that rises to 43% among large employers with 5,000 or more workers, compared to just 16% among smaller employers with 200 to 999 workers [5]. Even where a plan does cover a GLP-1 for weight loss, prior authorization is typically required, meaning your prescriber has to document criteria like BMI thresholds or related health conditions before the plan approves it. Manufacturer savings programs can also lower an insured patient's copay substantially. One pharmacy partner, for example, has advertised a Wegovy pill copay as low as $25 per month for eligible patients with qualifying commercial insurance [4]. None of this is a promise about what your specific plan will do. If cost is a major factor, it is worth asking your plan directly what its GLP-1 coverage criteria and cash-pay negotiated rate actually are before assuming either the best or worst case.

Without insurance

For people paying cash, the cheapest GLP-1 without insurance generally means one of the manufacturer direct-to-consumer discount programs described above, a compounded formulation, or a lower dose. As of the sources cited, the cheapest path to an authentic, FDA-approved GLP-1 without insurance is typically a manufacturer's own cash-pay program, currently landing in the roughly $199 to $449 per month range depending on the drug, dose, and whether an introductory rate applies [2, 3]. People searching for the cheapest online GLP-1 or the cheapest place to get a GLP-1 without insurance are often comparing these manufacturer programs against compounded options, which is the comparison the next section addresses directly.

Compounded GLP-1 pricing

Compounded semaglutide and tirzepatide are prepared by a licensed compounding pharmacy rather than manufactured by Novo Nordisk or Eli Lilly, and they are not FDA-approved; the FDA does not evaluate compounded medications for safety, effectiveness, or quality. Compounded combination formulations are not approved as combinations either.

Pricing for compounded GLP-1 programs varies by pharmacy, dose, formulation, and platform, and any figure should be treated as approximate. Public reporting on the broader telehealth and compounding market has described microdose compounded GLP-1 programs in roughly the $100 to $200 per month range, with standard-dose compounded programs often somewhat higher [6]. Exact numbers differ by provider and change often, so a specific quote from any given service, including Luvo, is the only reliable figure at the moment you're checking, not a number from an article.

Cost is also not the only reason people look at compounded formulations instead of, or alongside, the brand-name options above. For a broader look at what other medications and approaches exist in this category, see Ozempic alternatives.

Microdosing as a way to lower cost

Microdosing means using a lower dose of a GLP-1 medication than the standard therapeutic dose, at a provider's discretion, as part of a prescribed plan rather than a self-directed decision. Because compounded pricing is often tied to the amount of active medication in a formulation, a lower prescribed dose can mean a lower monthly cost compared to a standard-dose formulation of the same medication. That is a statement about how compounding costs are typically structured, not a claim about how a lower dose will affect your results, side effects, or weight; those questions are provider-dependent and vary by individual, and microdosing is not established to produce fewer side effects or better tolerability unless a specific study says so for a specific dose. For more on how tablet and injection microdosing formats compare, see GLP-1 tablets vs. injections (Microdosing), and for a fuller overview of what the approach involves, see the Microdosing program page or the Microdosing semaglutide: Complete guide.

A dose, and therefore a price, is not necessarily fixed for the length of treatment. Providers sometimes adjust dose over time based on how a person responds, including in cases where weight loss slows or plateaus; see The GLP-1 plateau: What to do when weight loss stalls for what that can look like and why it happens. Any dose change, in either direction, is a provider decision based on your individual response, not a default cost-cutting move.

Like any prescription medication, GLP-1s at any dose carry possible side effects, and a licensed provider is the right person to review those with you and decide what dose and format fit your health history.

‍

Forms and price ranges at a glance

Every figure in this table is approximate, sourced to the citations above, and subject to change. It is not a quote for any specific program, including Luvo's.

Common questions

Why is compounded cheaper?

Compounded formulations are prepared by a licensed compounding pharmacy rather than manufactured by the brand-name drugmaker, which changes the cost structure behind the product. This is a description of how pricing tends to work, not a claim that compounded is equivalent to, or a substitute for, the FDA-approved brand-name product it contains the same molecule as.

Does insurance cover compounded GLP-1s?

Generally, no, or only in limited circumstances. Most insurance coverage pathways for GLP-1s are built around the FDA-approved brand-name products, and compounded formulations typically fall outside standard pharmacy benefit coverage. If insurance coverage is your priority, ask your plan directly whether compounded formulations are covered under any circumstance, since this varies and can change.

Are there hidden costs?

Programs structured as a subscription, including Luvo's, are a recurring charge rather than a single purchase, and any legitimate program should make the recurring price, what is included, and how to cancel clear before you start. If a price you're offered is a discounted first month or an introductory rate, ask what it renews to and when. Luvo's current pricing, what a subscription includes, and cancellation terms are listed on the Pricing page and the Cancellation and Refund Policy.

Is cheaper worse?

Not necessarily, but price alone does not tell you about oversight, formulation quality, or whether a specific option is appropriate for you. A lower price from an unregulated marketplace with no health questionnaire and no licensed provider involved is a different situation than a lower price from a licensed compounding pharmacy working through provider review. Cost is one factor among several, including whether a licensed provider is reviewing your history before anything is prescribed.

Next steps

GLP-1 costs vary enough by drug, dose, insurance status, and format that the only way to know your real number is to check current pricing directly and have a licensed provider review what dose and format actually fit your health history. Nothing is prescribed or shipped without that review.

Explore Luvo's Microdosing Program.